TORONTO, Jan. 26 /CNW/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today filed the Company's Annual Report, Annual Information Form, Annual Proxy Circular and its 2009 Management Discussion and Analysis (MD&A) with financial statements and notes for the fiscal year ended October 31, 2009.
These documents, which are available on the Company's Website at www.mdsinc.com, can be accessed on the EDGAR section of the U.S. Securities and Exchange Commission's Website at www.sec.gov, and will be available on the Canadian Securities Administrators Website at www.sedar.com.
Upon request, hard copies of the Company's audited financial statements will be provided free of charge to security holders. They can be obtained by completing a Report Request form, which is available on MDSInc.com at http://www.mdsinc.com/investors/report_request_form.asp
About MDS Inc.
MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that customers need for the development of drugs and the diagnosis and treatment of disease. MDS Inc. is a leading global provider of innovative technologies for use in medical imaging and radiotherapeutics, sterilization, pharmaceutical contract research, and analytical instruments. MDS has more than 3,500 highly skilled people in 13 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.
SOURCE Nordion Inc.
For further information: For further information: MEDIA: Janet Ko, (905) 267-4226, firstname.lastname@example.org; INVESTORS: Catherine Love, (905) 267-4230, email@example.com